The future of translational biomedical research at Nazarbayev University by Saparov, A. et al.
ABSTRACTS 
T H E F U T U R E OF TRANSLATIONAL BIOMEDICAL RESEARCH 
AT NAZARBAYEV UNIVERSITY 
A. Saparov1,2*, K. Alibek2 ,3, V. Brusic1, M. Pignatelli2 
1) School of Science and Technology, Nazarbayev University, Astana, Kazakhstan; *asaparov@nu.edu.kz; 2) School of Medicine, 
Nazarbayev University, Astana, Kazakhstan; 3) National Medical Holding, Nazarbayev University, Astana, Kazakhstan 
The ultimate goal of fundamental biomedical research is to decipher mechanisms underlying the 
impairment of molecules, cells, tissues, and organs and subsequent dysfunction of the whole human body. 
Knowledge of these mechanisms helps discover and develop new approaches in the diagnosis, prevention 
and treatment of various diseases. Translational biomedical research enables the application of basic 
scientific discoveries to diagnostics, patient care and clinical practice. Thus, translational biomedical 
research is a link between fundamental research, clinical research and clinical practice. Transfer of 
discoveries from the bench to the bedside is a very complex and time consuming process that includes 
pre-clinical studies and several phases of clinical trials, along with the development of clinical guidelines 
and protocols, and the eventual implementation of best clinical practices. 
Recent rapid progress of biomedical research has transformed our understanding of health and 
disease. The completion of the Human Genome Project triggered new discoveries on the regulation of 
gene expression, allowing for a better understanding of the processes that characterize healthy conditions 
as well as the development of various diseases. Discoveries in the area of molecular medicine reveal the 
molecular mechanisms behind the normal function and dysfunction of cells during disease. Large-scale 
studies of the products of gene transcription (transcriptomics), protein profile (proteomics) and products 
of metabolism (metabolomics) indicate that every disease has a unique profile or "fingerprints" of its 
molecular products. Defining genomic, transcriptomic, proteomic and metabolomic profiles for each 
particular disease and for each particular patient allows for more precise diagnostics, better prevention and 
more effective treatment of the disease. Moreover, the necessity to analyze huge amounts of information 
requires the involvement of biomedical informatics, powerful computing capabilities and computer 
modeling. Collaboration between the School of Science and Technology, the School of Medicine and 
National Medical Holding as well as multidisciplinary, integrative and teamwork approaches will allow for 
the efficient transfer of discoveries in the area of fundamental biomedical research into clinical practice. 
As a result, medicine will become more personalized, preventive and proactive. The implementation of 
these approaches will improve the healthcare of the people of Kazakhstan and beyond. 
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